Malnutrition-Inflammation Complex Syndrome in Dialysis Patients: Causes and Consequences

American Journal of Kidney Diseases

Volumn 42, Issue 5, 2003, Pages 864-881

  Kalantar Zadeh, Kamyar ^a   Ikizler, T Alp ^b   Block, Gladys ^b   Avram, Morrel M ^b   Kopple, Joel D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Anemia; Atherosclerosis; Cardiovascular disease; Dialysis; Erythropoietin (EPO); Inflammation; Malnutrition inflammation complex syndrome (MICS); Outcome; Protein energy malnutrition (PEM); Reverse epidemiology

Indexed keywords

CREATINE; CYTOKINE; ERYTHROPOIETIN; HOMOCYSTEINE; UREMIC TOXIN;

ANEMIA; ANOREXIA; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CREATININE BLOOD LEVEL; DIETARY INTAKE; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPOALBUMINEMIA; HYPOCHOLESTEROLEMIA; INFLAMMATION; MALNUTRITION INFLAMMATION COMPLEX SYNDROME; OBESITY; OXIDATIVE STRESS; PROTEIN CALORIE MALNUTRITION; QUALITY OF LIFE; REVIEW;

EID: 0142157737     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajkd.2003.07.016     Document Type: Review

References (190)

1. US Renal Data Systems: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2003
2. Devereaux PJ, Schunemann HJ, Ravindran N, et al: Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: A systematic review and meta-analysis. JAMA 288:2449-2457, 2002
3. Eggers PW, Frankenfield DL, Greer JW, McClellan W, Owen WF Jr, Rocco MV: Comparison of mortality and intermediate outcomes between Medicare dialysis patients in HMO and fee for service. Am J Kidney Dis 39:796-804, 2002
4. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: Association among SF-36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 12:2797-2806, 2001
5. Carlson DM, Duncan DA, Naessens JM, Johnson WJ: Hospitalization in dialysis patients. Mayo Clin Proc 59:769-775, 1984
6. Fried L, Abidi S, Bernardini J, Johnston JR, Piraino B: Hospitalization in peritoneal dialysis patients. Am J Kidney Dis 33:927-933, 1999
7. Habach G, Bloembergen WE, Mauger EA, Wolfe RA, Port FK: Hospitalization among United States dialysis patients: Hemodialysis versus peritoneal dialysis. J Am Soc Nephrol 5:1940-1948, 1995
8. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9:S16-S23, 1998 (suppl 3)
9. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112-S119, 1998 (suppl 3)
10. US Renal Data System: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2001
11. Hirth RA, Held PJ, Orzol SM, Dor A: Practice patterns, case mix, Medicare payment policy, and dialysis facility costs. Health Serv Res 33:1567-1592, 1999
12. Garella S: The costs of dialysis in the USA. Nephrol Dial Transplant 12:S10-S21, 1997 (suppl 1)
13. Morbidity and mortality of dialysis. NIH Consens Statement 11:1-33, 1993
14. Eknoyan G, Beck GJ, Cheung AK, et al: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010-2019, 2002
15. Fung F, Sherrard DJ, Gillen DL, et al: Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis 40:307-314, 2002
16. Kalantar-Zadeh K, Supasyndh O, Lehn RS, McAllister CJ, Kopple JD: Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr 13:15-25, 2003
17. Bergstrom J, Lindholm B: Malnutrition, cardiac disease, and mortality. Perit Dial Int 19:S309-S314, 1999 (suppl 2)
18. Kalantar-Zadeh K, Kopple JD: Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38:1343-1350, 2001
19. Qureshi AR, Alvestrand A, Divino-Filho JC, et al: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13:S28-S36, 2002 (suppl 1)
20. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
21. Stenvinkel P, Heimburger O, Paultre F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
22. Bergstrom J: Inflammation, malnutrition, cardiovascular disease and mortality in end-stage renal disease. Pol Arch Med Wewn 104:641-643, 2000
23. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38:1251-1263, 2001
24. Pecoits-Filho R, Lindholm B, Stenvinkel P: The malnutrition, inflammation, and atherosclerosis (M1A) syndrome - The heart of the matter. Nephrol Dial Transplant 17:S28-S31, 2002 (suppl 11)
25. Torun B, Chew F: Protein-energy malnutrition, in Shils M, Olson J, Shike M, Ross A (eds): Modern Nutrition in Health and Disease (ed 9). Baltimore, MD, William & Wilkins, 1999, pp 963-988
26. Kopple JD: Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J 43:246-250, 1997
27. Kopple JD, Zhu X, Lew NL, Lowrie EG: Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 56:1136-1148, 1999
28. Mehrotra R, Kopple JD: Nutritional management of maintenance dialysis patients: Why aren't we doing better? Annu Rev Nutr 21:343-379, 2001
29. Kalantar-Zadeh K, Kopple J: Nutritional management of hemodialysis patients, in Massry S (ed): Nutritional Management of Renal Disease (ed 2). Philadelphia, PA, Lippincott, Williams & Wilkins, 2003, pp 183-198
30. Kalantar-Zadeh K, Kopple JD, Deepak S, Block D, Block G: Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr 12:17-31, 2002
31. Kopple JD: McCollum Award Lecture, 1996: Protein-energy malnutrition in maintenance dialysis patients. Am J Clin Nutr 65:1544-1557, 1997
32. Kopple JD: Pathophysiology of protein-energy wasting in chronic renal failure. J Nutr 129:S247-S251, 1999 (suppl 1)
33. Mehrotra R, Kopple J: Causes of protein-energy malnutrition in chronic renal failure, in Kopple J, Massry S (eds): Nutritional Management of Renal Disease (ed 2). Philadelphia, PA, Lippincott, Williams & Wilkins, 2003, pp 167-182
34. Qureshi AR, Alvestrand A, Danielsson A, et al: Factors predicting malnutrition in hemodialysis patients: A cross-sectional study. Kidney Int 53:773-782, 1998
35. Bergstrom J: Why are dialysis patients malnourished? Am J Kidney Dis 26:229-241, 1995
36. Kopple JD, Greene T, Chumlea WC, et al: Relationship between nutritional status and the glomerular filtration rate: Results from the MDRD study. Kidney Int 57:1688-1703, 2000
37. Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM: Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 6:1386-1391, 1995
38. Kalantar-Zadeh K, Kleiner M, Dunne E, et al: Total iron-binding capacity-estimated transferrin correlates with the nutritional Subjective Global Assessment in hemodialysis patients. Am J Kidney Dis 31:263-272, 1998
39. Enia G, Sicuso C, Alati G, Zoccali C: Subjective Global Assessment of nutrition in dialysis patients. Nephrol Dial Transplant 8:1094-1098, 1993
40. Chertow GM: Estimates of body composition as intermediate outcome variables: Are DEXA and BIA ready for prime time? J Ren Nutr 9:138-141, 1999
41. Dumler F: Use of bioelectric impedance analysis and dual-energy X-ray absorptiometry for monitoring the nutritional status of dialysis patients. ASAIO J 43:256-260, 1997
42. Pollock CA, Allen BJ, Warden RA, et al: Total body nitrogen by neutron activation analysis in maintenance dialysis patients. Am J Kidney Dis 16:38-45, 1990
43. Arora P, Strauss BJ, Borovnicar D, Stroud D, Atkins RC, Kerr PG: Total body nitrogen predicts long-term mortality in haemodialysis patients - A single-centre experience. Nephrol Dial Transplant 13:1731-1736, 1998
44. Boddy K, King PC, Lindsay RM, Briggs JD, Winchester JF, Kennedy AC: Total body potassium in non-dialysed and dialysed patients with chronic renal failure. Br Med J 1:771-775, 1972
45. Ikizler TA, Hakim RM: Nutrition in end-stage renal disease. Kidney Int 50:343-357, 1996
46. Kalantar-Zadeh K, Dunne E, Nixon K, et al: Near infra-red interactance for nutritional assessment of dialysis patients. Nephrol Dial Transplant 14:169-175, 1999
47. Kalantar-Zadeh K, Block G, Kelly MP, Schroepfer C, Rodriguez RA, Humphreys MH: Near infra-red interactance for longitudinal assessment of nutrition in dialysis patients. J Ren Nutr 11:23-31, 2001
48. Kalantar-Zadeh K, Kopple J: Malnutrition as a cause of morbidity and mortality in dialysis patients, in Kopple J, Massry S (eds): Nutritional Management of Renal Disease (ed 2). Philadelphia, PA, Lippincott, Williams & Wilkins, 2003, pp 433-466
49. Kalantar-Zadeh K, Block G, McAllister C, Kopple M: Association between appetite and inflammation, anemia, EPO dose, and quality of life in dialysis. J Am Soc Nephrol 13:S223A, 2002 (suppl; abstr P0797).
50. Culp K, Flanigan M, Dudley J, Taylor L, Bissen T, Garrison S: Using the Quetelet body mass index as a mortality indicator for patients starting renal replacement therapy. ANNA J 25:321-330; discussion, 331-322, 1998
51. Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW: Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 16:2386-2394, 2001
52. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13:1061-1066, 2002
53. Blumenkrantz MJ, Kopple JD, Gutman RA, et al: Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 33:1567-1585, 1980
54. Pollock CA, Ibels LS, Allen BJ, et al: Total body nitrogen as a prognostic marker in maintenance dialysis. J Am Soc Nephrol 6:82-88, 1995
55. Wolfson M, Strong CJ, Minturn D, Gray DK, Kopple JD: Nutritional status and lymphocyte function in maintenance hemodialysis patients. Am J Clin Nutr 39:547-555, 1984
56. Kaysen GA, Levin NW: Why measure serum albumin levels? J Ren Nutr 12:148-150, 2002
57. Sreedhara R, Avram MM, Blanco M, Batish R, Mittman N: Prealbumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis. Am J Kidney Dis 28:937-942, 1996
58. Kopple JD, Mehrotra R, Suppasyndh O, Kalantar-Zadeh K: Observations with regard to the National Kidney Foundation K/DOQI clinical practice guidelines concerning serum transthyretin in chronic renal failure. Clin Chem Lab Med 40:1308-1312, 2002
59. Neyra NR, Hakim RM, Shyr Y, Ikizler TA: Serum transferrin and serum prealbumin are early predictors of serum albumin in chronic hemodialysis patients. J Ren Nutr 10:184-190, 2000
60. Avram MM, Fein PA, Antignani A, et al: Cholesterol and lipid disturbances in renal disease: The natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis. Am J Med 87:55N-60N, 1989
61. Iseki K, Yamazato M, Tozawa M, Takishita S: Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 61:1887-1893, 2002
62. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
63. Cooper BA, Bartlett LH, Aslani A, Allen BJ, Ibels LS, Pollock CA: Validity of Subjective Global Assessment as a nutritional marker in end-stage renal disease. Am J Kidney Dis 40:126-132, 2002
64. Visser R, Dekker FW, Boeschoten EW, Stevens P, Krediet RT: Reliability of the 7-point Subjective Global Assessment scale in assessing nutritional status of dialysis patients. Adv Perit Dial 15:222-225, 1999
65. Kaysen GA: The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol 12:1549-1557, 2001
66. Kaysen GA, Dubin JA, Muller HG, Mitch WE, Rosales LM, Levin NW: Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int 61:2240-2249, 2002
67. Grodstein GP, Blumenkrantz MJ, Kopple JD: Nutritional and metabolic response to catabolic stress in uremia. Am J Clin Nutr 33:1411-1416, 1980
68. Newman Dorland W, Anderson D: Dorland's Illustrated Medical Dictionary, Philadelphia, PA, Saunders, 2000
69. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454, 1999
70. Kushner I: Acute phase proteins, in Rose B, Wellesley MA (eds): UpToDate. Boston, MA, UpToDate, 2003
71. Streetz KL, Wustefeld T, Klein C, Manns MP, Trautwein C: Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisy-le-grand) 47:661-673, 2001
72. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP: New insights into the biology of the acute phase response. J Clin Immunol 19:203-214, 1999
73. Owen WF, Lowrie EG: C-Reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54:627-636, 1998
74. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469-476, 2000
75. Zoccali C, Benedetto FA, Mallamaci F, et al: Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens 18:1207-1213, 2000
76. Iseki K, Tozawa M, Yoshi S, Fukiyama K: Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 14:1956-1960, 1999
77. Noh H, Lee SW, Kang SW, et al: Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 18:387-394, 1998
78. Fanti P, Sawaya BP, Custer LJ, Franke AA: Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients. J Am Soc Nephrol 10:864-871, 1999
79. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134:629-636, 2001
80. Shlipak MG, Chertow GC, Massie BM: Beware the rising creatinine level. J Card Fail 9:26-28, 2003
81. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137:555-562, 2002
82. Lowbeer C, Stenvinkel P, Pecoits-Filho R, et al: Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med 253:153-160, 2003
83. Kalantar-Zadeh K, Kopple J: Inflammation in renal failure, in Rose BD, Post TW (eds): UpToDate, vol 10.2. Boston, MA, UpToDate, 2003
84. Kalantar-Zadeh K, Stenvinkel P, Barba L, Pillon L, Kopple J: Nutrition and inflammation in renal insufficiency. Adv Ren Replace Ther (in press)
85. Kalantar-Zadeh K, Rodriguez R, Humphreys M: Association between serum ferritin and measures of inflammation, nutrition, and iron in hemodialysis patients. Nephrol Dial Transplant (in press)
86. Pecoits-Filho R, Heimburger O, Barany P, et al: Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 41:1212-1218, 2003
87. Kimmel PL, Phillips TM, Simmens SJ, et al: Immunologic function and survival in hemodialysis patients. Kidney Int 54:236-244, 1998
88. Bologa RM, Levine DM, Parker TS, et al: Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107-114, 1998
89. Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684-1688, 2002
90. Stenvinkel P, Barany P, Heimburger O, Pecoits-Filho R, Lindholm B: Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Kidney Int 80:S 103-S 108, 2002 (suppl)
91. Tatli MM, Vural H, Koc A, Kosecik M, Atas A: Altered anti-oxidant status and increased lipid peroxidation in marasmic children. Pediatr Int 42:289-292, 2000
92. Yeun JY, Kaysen GA: Factors influencing serum albumin in dialysis patients. Am J Kidney Dis 32:S118-S125, 1998 (suppl 4)
93. Stenvinkel P, Barany P, Chung SH, Lindholm B, Heimburger O: A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. Nephrol Dial Transplant 17:1266-1274, 2002
94. Kaizu Y, Kimura M, Yoneyama T, Miyaji K, Hibi I, Kumagai H: Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 31:93-100, 1998
95. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW: Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. J Clin Invest 83:1614-1622, 1989
96. Espat NJ, Copeland EM, Moldawr LL: Tumor necrosis factor and cachexia: A current perspective. Surg Oncol 3:255-262, 1994
97. McCarthy DO: Tumor necrosis factor alpha and interleukin-6 have differential effects on food intake and gastric emptying in fasted rats. Res Nurs Health 23:222-228, 2000
98. Kaysen GA, Chertow GM, Adhikarla R, Young B, Ronco C, Levin NW: Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int 60:333-340, 2001
99. Kaysen GA, Stevenson FT, Depner TA: Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 29:658-668, 1997
100. Ginn HE, Frost A, Lacy WW: Nitrogen balance in hemodialysis patients. Am J Clin Nutr 21:385-393, 1968
101. Kaysen GA, Dubin JA, Muller HG, Rosales LM, Levin NW: The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group. Kidney Int 58:346-352, 2000
102. Leon JB, Majerle AD, Soinski JA, Kushner I, Ohri-Vachaspati P, Sehgal AR: Can a nutrition intervention improve albumin levels among hemodialysis patients? A pilot study. J Ren Nutr 11:9-15, 2001
103. Kuhlmann MK, Schmidt F, Kohler H: High protein/energy vs standard protein/energy nutritional regimen in the treatment of malnourished hemodialysis patients. Miner Electrolyte Metab 25:306-310, 1999
104. Pupim LB, Flakoll PJ, Brouillette JR, Levenhagen DK, Hakim RM, Ikizler TA: Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest 110:483-492, 2002
105. Caglar K, Fedje L, Dimmitt R, Hakim RM, Shyr Y, Ikizler TA: Therapeutic effects of oral nutritional supplementation during hemodialysis. Kidney Int 62:1054-1059, 2002
106. Stenvinkel P, Holmberg I, Heimburger O, Diczfalusy U: A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients. Nephrol Dial Transplant 13:2594-2600, 1998
107. Hulsewe KW, van Acker BA, von Meyenfeldt MF, Soeters PB: Nutritional depletion and dietary manipulation: Effects on the immune response. World J Surg 23:536-544, 1999
108. De Simone C, Famularo G, Tzantzoglou S, Trinchieri V, Moretti S, Sorice F: Carnitine depletion in peripheral blood mononuclear cells from patients with AIDS: Effect of oral L-carnitine. AIDS 8:655-660, 1994
109. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557-1565, 2002
110. Kaysen GA: Malnutrition and the acute-phase reaction in dialysis patients - How to measure and how to distinguish. Nephrol Dial Transplant 15:1521-1524, 2000
111. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63:793-808, 2003
112. Ifudu O, Uribarri J, Rajwani I, et al: Low hematocrit may connote a malnutrition-inflammation syndrome in hemodialysis patients. Dial Transplant 845 31:845-878, 2002
113. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J: Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15:953-960, 2000
114. Riella MC: Malnutrition in dialysis: Malnourishment or uremic inflammatory response? Kidney Int 57:1211-1232, 2000
115. Barany P, Divino Filho JC, Bergstrom J: High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 29:565-568, 1997
116. Stenvinkel P, Alvestrand A: Inflammation in end-stage renal disease: Sources, consequences, and therapy. Semin Dial 15:329-337, 2002
117. Gunnell J, Yeun JY, Depner TA, Kaysen GA: Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 33:63-72, 1999
118. Goicoechea M, Martin J, de Sequera P, et al: Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 54:1337-1343, 1998
119. Sitter T, Bergner A, Schiffl H: Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant 15:1207-1211, 2000
120. Kalantar-Zadeh K, McAllister C, Lehn R, Lee G, Nissenson A, Kopple J: Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 42:761-773, 2003.
121. Hurot JM, Cucherat M, Haugh M, Fouque D: Effects of L-carnitine supplementation in maintenance hemodialysis patients: A systematic review. J Am Soc Nephrol 13:708-714, 2002
122. Navarro JF, Mora C: In-depth review: Effect of androgens on anemia and malnutrition in renal failure: Implications for patients on peritoneal dialysis. Perit Dial Int 21:14-24, 2001
123. Brox AG, Zhang F, Guyda H, Gagnon RF: Subtherapeutic erythropoietin and insulin-like growth factor-1 correct the anemia of chronic renal failure in the mouse. Kidney Int 50:937-943, 1996
124. Voulgari PV, Kolios G, Papadopoulos GK, Katsaraki A, Seferiadis K, Drosos AA: Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol 92:153-160, 1999
125. Stenvinkel P: The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant 16:S36-S40, 2001 (suppl 7)
126. Stenvinkel P, Barany P: Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; Links to inflammation and oxidative stress. Nephrol Dial Transplant 17:S32-S37, 2002 (suppl 5)
127. Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH: Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis 37:564-572, 2001
128. Kalantar-Zadeh K, Luft FC, Humphreys MH: Moderately high serum ferritin concentration is not a sign of iron overload in dialysis patients. Kidney Int 56:758-759, 1999
129. Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL: Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322:1689-1692, 1990
130. Jelkmann W, Pagel H, Wolff M, Fandrey J: Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 50:301-308, 1992
131. Means RT Jr, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80:1639-1647, 1992
132. Schooley JC, Kullgren B, Allison AC: Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias. Br J Haematol 67:11-17, 1987
133. Drueke T, Witko-Sarsat V, Massy Z, et al: Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 106:2212-2217, 2002
134. Becker AE, de Boer OJ, van Der Wal AC: The role of inflammation and infection in coronary artery disease. Annu Rev Med 52:289-297, 2001
135. Girndt M, Kaul H, Sester U, et al: Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 62:949-955, 2002
136. Kaplan N: Risk factor for atherosclerotic disease, in Braunwald EZD, Libby P (eds): Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia, PA, Saunders, 2001, pp 1010-1039
137. Haubitz M, Brunkhorst R: C-Reactive protein and chronic Chlamydia pneumoniae infection-Long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 16:809-815, 2001
138. Stenvinkel P, Heimburger O, Jogestrand T: Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: Association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 39:274-282, 2002
139. Daugherty A, Dunn JL, Rateri DL, Heinecke JW: Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94:437-444, 1994
140. Pecoits-Filho R, Stenvinkel P, Marchlewska A, et al: A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. Kidney Int Suppl 84:S172-S176, 2003
141. Mezzano D, Pais EO, Aranda E, et al: Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 60:1844-1850, 2001
142. Chung SH, Stenvinkel P, Heimburger O, Bergstrom J, Lindholm B: Prevention and treatment of the malnutrition, inflammation and atherosclerosis (MIA) syndrome in uremic patients. Pol Arch Med Wewn 104:645-654, 2000
143. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7:728-736, 1996
144. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK: Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55:1560-1567, 1999
145. Iseki K, Ikemiya Y, Fukiyama K: Predictors of end-stage renal disease and body mass index in a screened cohort. Kidney Int Suppl 63:S 169-S 170, 1997
146. Lowrie EG: History and organization of the National Cooperative Dialysis Study. Kidney Int Suppl 1:S1-S7, 1983
147. Ritz E: Why are lipids not predictive of cardiovascular death in the dialysis patient? Miner Electrolyte Metab 22:9-12, 1996
148. Lowrie E: Conceptual model for a core pathobiology of uremia with special reference to anemia, malnourishment, and mortality among dialysis patients. Semin Dial 10:115-129, 1997.
149. Suliman ME, Lindholm B, Barany P, Bergstrom J: Hyperhomocysteinemia in chronic renal failure patients: Relation to nutritional status and cardiovascular disease. Clin Chem Lab Med 39:734-738, 2001
150. Suliman ME, Qureshi AR, Barany P, et al: Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. Kidney Int 57:1727-1735, 2000
151. Suliman ME, Stenvinkel P, Barany P, Heimburger O, Anderstam B, Lindholm B: Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: Influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. Am J Kidney Dis 41:S89-S95, 2003 (suppl 2)
152. Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J: Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 116:59-62, 1995
153. Iseki K, Miyasato F, Tokuyama K, et al: Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 51:1212-1217, 1997
154. Marckmann P: Nutritional status and mortality of patients in regular dialysis therapy. J Intern Med 226:429-432, 1989
155. Lawson JA, Lazarus R, Kelly JJ: Prevalence and prognostic significance of malnutrition in chronic renal insufficiency. J Ren Nutr 11:16-22, 2001
156. Canada-USA Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7:198-207, 1996
157. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Am J Kidney Dis 35:S1-S140, 2000 (suppl 2)
158. Canada-USA (CANUSA) Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7:198-207, 1996
159. Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC: A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant 14:1732-1738, 1999
160. Kopple JD, Massry SG: Nutritional management of renal disease, in Kopple JD (ed): Nutritional Management of Nondialyzed Patients With Chronic Renal Failure. Baltimore, MD, William & Wilkins, 1996, pp 479-531
161. Mortelmans AK, Duym P, Vandenbroucke J, et al: Intradialytic parenteral nutrition in malnourished hemodialysis patients: A prospective long-term study. JPEN J Parenter Enteral Nutr 23:90-95, 1999
162. Koretz RL: Does nutritional intervention in protein-energy malnutrition improve morbidity or mortality? J Ren Nutr 9:119-121, 1999
163. Sharma M, Rao M, Jacob S, Jacob CK: A controlled trial of intermittent enteral nutrient supplementation in maintenance hemodialysis patients. J Ren Nutr 12:229-237, 2002
164. Foulks CJ: The effect of intradialytic parenteral nutrition on hospitalization rate and mortality in malnourished hemodialysis patients. J Ren Nutr 4:5-10, 1994
165. Chertow GM, Owen WF, Lazarus JM: Outcomes of older patients receiving chronic dialysis. JAMA 272:274, 1994
166. Capelli JP, Kushner H, Camiscioli TC, Chen SM, Torres MA: Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis 23:808-816, 1994
167. Siskind MS, Lien YH: Effect of intradialytic parenteral nutrition on quality of life in hemodialysis patients. Int J Artif Organs 16:599-603, 1993
168. Pupim LB, Kent P, Hakim R: The potential of intradialytic parenteral nutrition: A review. Miner Electrolyte Metab 25:317-323, 1999
169. Foulks CJ: An evidence-based evaluation of intradialytic parenteral nutrition. Am J Kidney Dis 33:186-192, 1999
170. Boccanfuso JA, Hutton M, McAllister B: The effects of megestrol acetate on nutritional parameters in a dialysis population. J Ren Nutr 10:36-43, 2000
171. Semeniuk J, Shalansky KF, Taylor N, Jastrzebski J, Cameron EC: Evaluation of the effect of intravenous L-carnitine on quality of life in chronic hemodialysis patients. Clin Nephrol 54:470-477, 2000
172. Chazot C, Laurent G, Charra B, et al: Malnutrition in long-term haemodialysis survivors. Nephrol Dial Transplant 16:61-69, 2001
173. Johannsson G, Bengtsson BA, Ahlmen J: Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: Anabolic effect and functional improvement. Am J Kidney Dis 33:709-717, 1999
174. Fouque D, Peng SC, Shamir E, Kopple JD: Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients. Kidney Int 57:646-654, 2000
175. Johnson CA: Use of androgens in patients with renal failure. Semin Dial 13:36-39, 2000
176. Chang JW, Yang WS, Min WK, Lee SK, Park JS, Kim SB: Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients. Am J Kidney Dis 39:1213-1217, 2002
177. Seliger SL, Weiss NS, Gillen DL, et al: HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int 61:297-304, 2002
178. Stenvinkel P, Andersson P, Wang T, et al: Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure? J Intern Med 246:503-507, 1999
179. Boaz M, Smetana S, Weinstein T, et al: Secondary Prevention With Antioxidants of Cardiovascular Disease in Endstage Renal Disease (SPACE): Randomised placebo-controlled trial. Lancet 356:1213-1218, 2000
180. Abbey M: The importance of vitamin E in reducing cardiovascular risk. Nutr Rev 53:S28-S32, 1995 (suppl 1)
181. Hoogwerf BJ, Young JB: The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not. Cleve Clin J Med 67:287-293, 2000
182. Lonn E, Yusuf S, Hoogwerf B, et al: Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: Results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 25:1919-1927, 2002
183. Clermont G, Lecour S, Cabanne JF, et al: Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients. Free Radic Biol Med 31:233-241, 2001
184. Bloembergen WE, Hakim RM, Stannard DC, et al: Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis 33:1-10, 1999
185. Schindler R, Boenisch O, Fischer C, Frei U: Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol 53:452-459, 2000
186. Memoli B, Minutolo R, Bisesti V, et al: Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes. Am J Kidney Dis 39:266-273, 2002
187. Beto JA, Bansal VK, Hart J, McCarthy M, Roberts D: Hemodialysis prognostic nutrition index as a predictor for morbidity and mortality in hemodialysis patients and its correlation to adequacy of dialysis. Council on Renal Nutrition National Research Question Collaborative Study Group. J Ren Nutr 9:2-8, 1999
188. Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT: Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis 35:69-79, 2000
189. Pecoits-Filho R, Lindholm B, Stenvinkel P: End-stage renal disease: A state of chronic inflammation and hyperleptinemia. Eur J Clin Invest 33:527-528, 2003
190. Harty JC, Boulton H, Curvell J, et al: The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. Kidney Int 45:103-109, 1994